Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Biovail has appointed Fred Nicklas as vice president of US commercial operations of BTA Pharmaceuticals, effective May 4, 2009.
Subscribe to our email newsletter
In this role, Mr Nicklas will oversee sales, marketing and managed care efforts for BTA’s products.
Prior to joining Biovail, Mr Nicklas was senior director of epilepsy marketing at Valeant Pharmaceuticals. Prior to that, he spent two years as group product director for Keppra at UCB Pharmaceuticals and eight years at AstraZeneca, where he was director of brand communications for Seroquel and director of managed markets for Nexium.